Medical Instruments & Supplies More
- 1001-5000 Employees
- Based in Waltham, Massachusetts
Repligen Corporation (NASDAQ:RGEN) is a bioprocessing company focused on the development, manufacture and commercialization of highly innovative products used to improve the interconnected phases of the biological drug manufacturing process. Repligen's portfolio includes protein products (Protein A affinity ligands, cell culture growth factors), chromatography products (OPUS® pre-packed…More columns, chromatography resins, ELISA kits) and filtration products (XCell™ ATF Systems, TangenX™ Sius™ TFF cassettes). The company's bioprocessing products are sold to major life sciences companies, biopharmaceutical development companies and contract manufacturing organizations worldwide.
REPORT RATINGS4.8 / 5.0 (68)
Repligen Corporation reports have an aggregate usefulness score of 4.8 based on 68 reviews.
Most Recent Responsibility Report
2020 Sustainability Report
Our service enables potential investors to review the most recent and archived Repligen Corporation Sustainability Report, Repligen Corporation Corporate Social Responsibility Report, Repligen Corporation CSR Report, Repligen Corporation Corporate Responsibility, Repligen Corporation CR Report, Repligen Corporation Citizenship Report, Repligen Corporation ESG Report, and Repligen Corporation Environmental Report online.